Treatment with rivastigmine or galantamine and risk of urinary incontinence: results from a Dutch database study.

Kröger, Edeltraut; Van Marum, Rob; Souverein, Patrick; Carmichael, Pierre-Hugues; Egberts, Toine

Kröger, Edeltraut; Van Marum, Rob; Souverein, Patrick; Carmichael, Pierre-Hugues; Egberts, Toine.

Affiliation

Kröger E; Centre d'excellence sur le vieillissement de Québec, Centre de recherche du CHU de Québec, Québec, Canada; Utrecht University, Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands.

Pharmacoepidemiol Drug Saf ; 24(3): 276-85, 2015 Mar.

Article in En | MEDLINE | ID: mdl-25652526

Subject(s)

Cholinesterase Inhibitors/adverse effects; Databases, Factual; Galantamine/adverse effects; Rivastigmine/adverse effects; Urinary Incontinence/chemically induced; Urinary Incontinence/epidemiology; Aged; Aged, 80 and over; Alzheimer Disease/drug therapy; Alzheimer Disease/epidemiology; Cohort Studies; Cross-Over Studies; Databases, Factual/trends; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Netherlands/epidemiology; Risk Factors; Treatment Outcome

Key words

Alzheimer disease; cholinesterase inhibitors; database cohort study; pharmacoepidemiology; urinary incontinence

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Incontinence / Cholinesterase Inhibitors / Databases, Factual / Rivastigmine / Galantamine Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2015 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google